Alnylam Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 1.57B 405M 2025-06
Arrowhead Research USD -179089000 548.7M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -71052000 1B 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Takeda JPY 150.63B 257.93B 2025-06
Tectonic Therapeutic USD -17716000 5.02M 2024-09
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06
Xencor USD -31075000 17.19M 2025-06


Alnylam Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.